BRIEF-U.S. Food And Drug Administration Approves Opdivo Qvantig Injection, For Subcutaneous Use In Most Previously Approved Adult, Solid Tumor Opdivo Indications
ReutersDec 27, 2024 10:39 PM
Dec 27 (Reuters) - Bristol-Myers Squibb Co BMY.N:
U.S. FOOD AND DRUG ADMINISTRATION APPROVES OPDIVO QVANTIG™ (NIVOLUMAB AND HYALURONIDASE-NVHY) INJECTION, FOR SUBCUTANEOUS USE IN MOST PREVIOUSLY APPROVED ADULT, SOLID TUMOR OPDIVO® (NIVOLUMAB) INDICATIONS1,2
Source text: ID:nBwCDx9La
Further company coverage: BMY.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Investing in Industrials Stocks
TradingKey - Industrials are having a remarkable 2025 recovery, quietly but powerfully. No longer a defensively minded, yield-driven sector, they are riding waves of structural change from geopolitics and AI infrastructure to the great global supply chain reshore. While the S&P 500 continues to...TradingKey
Fri, Aug 1
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.TradingKey
Fri, Aug 1
Berkshire Hathaway FY2025 Second Quarter Earnings Preview
TradingKey - The Q2 2025 earnings report for Berkshire Hathaway is expected to be released on August 2. Below are the market expectations for Berkshire Hathaway’s Q2 2025 revenue and earnings per share (EPS):TradingKey
Thu, Jul 31
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,TradingKey
Wed, Jul 23
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics.TradingKey
Mon, May 26
.jpg)
